1. Pinto A, Howitt B. Uterine adenosarcoma. Arch Pathol Lab Med. 2016; 140:286–90.
Article
2. Elshafie M, Rahimi S, Ganesan R, Hirschowitz L. Müllerian adenosarcoma arising in a subserosal adenomyoma. Int J Surg Pathol. 2013; 21:186–9.
Article
3. McCluggage WG. Müllerian adenosarcoma of the female genital tract. Adv Anat Pathol. 2010; 17:122–9.
4. Raffaelli R, Piazzola E, Zanconato G, Fedele L. A rare case of extrauterine adenosarcoma arising in endometriosis of the rectovaginal septum. Fertil Steril. 2004; 81:1142–4.
Article
5. Gollard R, Kosty M, Bordin G, Wax A, Lacey C. Two unusual presentations of mullerian adenosarcoma: case reports, literature review, and treatment considerations. Gynecol Oncol. 1995; 59:412–22.
6. Verschraegen CF, Vasuratna A, Edwards C, et al. Clinicopathologic analysis of Müllerian adenosarcoma: the M.D. Anderson Cancer Center experience. Oncol Rep. 1998; 5:939–44.
7. Liu L, Davidson S, Singh M. Müllerian adenosarcoma of vagina arising in persistent endometriosis: report of a case and review of the literature. Gynecol Oncol. 2003; 90:486–90.
Article
8. Clarke BA, Mulligan AM, Irving JA, McCluggage WG, Oliva E. Müllerian adenosarcomas with unusual growth patterns: staging issues. Int J Gynecol Pathol. 2011; 30:340–7.
9. Prat J. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet. 2009; 104:177–8.
Article
10. Jha P, Ansari C, Coakley FV, et al. Case report: Imaging of Müllerian adenosarcoma arising in adenomyosis. Clin Radiol. 2009; 64:645–8.
11. Major FJ, Blessing JA, Silverberg SG, et al. Prognostic factors in early-stage uterine sarcoma: a Gynecologic Oncology Group study. Cancer. 1993; 71(4 Suppl):1702–9.
Article
12. Abeler VM, Royne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB. Uterine sarcomas in Norway: a histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology. 2009; 54:355–64.
Article
13. Early HM, McGahan JP, Naderi S, Lamba R, Fananapazir G. Mullerian adenosarcoma: a malignant progression of adenomyosis? Pictorial review with multimodality imaging. J Ultrasound Med. 2015; 34:2109–13.
14. Bocklage T, Lee KR, Belinson JL. Uterine Müllerian adenosarcoma following adenomyoma in a woman on tamoxifen therapy. Gynecol Oncol. 1992; 44:104–9.
15. Oda Y, Nakanishi I, Tateiwa T. Intramural Müllerian adenosarcoma of the uterus with adenomyosis. Arch Pathol Lab Med. 1984; 108:798–801.
16. Clement PB, Scully RE. Müllerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol. 1990; 21:363–81.
17. Howitt BE, Sholl LM, Dal Cin P, et al. Targeted genomic analysis of Müllerian adenosarcoma. J Pathol. 2015; 235:37–49.
Article
18. Chen Z, Hong B, Drozd-Borysiuk E, Coffin C, Albritton K. Molecular cytogenetic characterization of a case of Müllerian adenosarcoma. Cancer Genet Cytogenet. 2004; 148:129–32.
Article
19. Gilks CB, Clement PB, Hart WR, Young RH. Uterine adenomyomas excluding atypical polypoid adenomyomas and adenomyomas of endocervical type: a clinicopathologic study of 30 cases of an underemphasized lesion that may cause diagnostic problems with brief consideration of adenomyomas of other female genital tract sites. Int J Gynecol Pathol. 2000; 19:195–205.
Article
20. Gallardo A, Prat J. Müllerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma. Am J Surg Pathol. 2009; 33:278–88.